The Federation of Asian Biotech Associations (FABA) will host special panel on the challenges in building innovation in pharma and biopharma sectors during BioAsia 2022 scheduled to be held from February 24-25. The theme is titled as‘Future ready’.



This two-days event will focus on exploring pharma and healthcare industry current position and their future in light of novel approaches and capabilities beyond the pandemic. BioAsia 2022 platform will be shared by leaders from the industry, academia, and governments from more than 70 countries to address the wide-ranging needs of the healthcare system.



FABA being at the forefront of promoting innovation and entrepreneurship in the biotech industry, academia, and healthcare sector is organizing a panel discussion as a part of BioAsia 2022 on “Challenges in building innovation engine in pharma and biopharma sectors”. The discussion will focus on proposing solutions to promote innovation in biotech and pharma sectors, on February 25 at 9:30 am.



The session will be moderated by Uday Saxena, Co-founder and CEO ReaGene Innovations. The panelists who will share the stage are Ashwini Nangia, Professor, University of Hyderabad; Vinay Nandicoori, director- CCMB; Satakarni Makkapati, president & head, biologics, Aurobindo Pharma; Gagandeep Kang, CMC Vellore (former director of THSTI); and Dr. Girish Krishnamurthy, CEO TATA Medical and Diagnostics Ltd.